Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol attenuates methamphetamine-induced conditioned place preference via the Sigma1R/AKT/GSK-3β/CREB signaling pathway in rats
Genmeng Yang, Liu Liu, Ruilin Zhang, et al.
Toxicology Research (2020) Vol. 9, Iss. 3, pp. 202-211
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Francisco Navarrete, María S. García‐Gutiérrez, Ani Gasparyan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 59
The molecular activity of cannabidiol in the regulation of Nrf2 system interacting with NF-κB pathway under oxidative stress
Sinemyiz Atalay, Agnieszka Gęgotek, Elżbieta Skrzydlewska
Redox Biology (2022) Vol. 57, pp. 102489-102489
Open Access | Times Cited: 54
Cannabidiol and substance use disorder: Dream or reality
Saeideh Karimi‐Haghighi, Yasaman Razavi, Daniela Iezzi, et al.
Neuropharmacology (2022) Vol. 207, pp. 108948-108948
Open Access | Times Cited: 33
Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals
Ewa Galaj, Zheng‐Xiong Xi
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 134-134
Open Access | Times Cited: 43
Cannabidiol in the context of substance use disorder treatment: A systematic review
Victoria Paulus, Joël Billieux, Amine Benyamina, et al.
Addictive Behaviors (2022) Vol. 132, pp. 107360-107360
Closed Access | Times Cited: 27
Addictive drugs modify neurogenesis, synaptogenesis and synaptic plasticity to impair memory formation through neurotransmitter imbalances and signaling dysfunction
Ameneh Rezayof, Zahra Ghasemzadeh, Oveis Hosseinzadeh Sahafi
Neurochemistry International (2023) Vol. 169, pp. 105572-105572
Closed Access | Times Cited: 13
Cannabidiol efficiently suppressed the acquisition and expression of methamphetamine-induced conditioned place preference in the rat
Mahsa Anooshe, Kiana Nouri, Saeideh Karimi‐Haghighi, et al.
Behavioural Brain Research (2021) Vol. 404, pp. 113158-113158
Closed Access | Times Cited: 29
Involvement of Hippocampal D1-Like Dopamine Receptors in the Inhibitory Effect of Cannabidiol on Acquisition and Expression of Methamphetamine-Induced Conditioned Place Preference
Kiana Nouri, Mahsa Anooshe, Saeideh Karimi‐Haghighi, et al.
Neurochemical Research (2021) Vol. 46, Iss. 8, pp. 2008-2018
Closed Access | Times Cited: 20
Cannabidiol modulates the METH-induced conditioned place preference through D2-like dopamine receptors in the hippocampal CA1 region
Amir Arash Hassanlou, Shole Jamali, Kimia RayatSanati, et al.
Brain Research Bulletin (2021) Vol. 172, pp. 43-51
Closed Access | Times Cited: 18
Cannabidiol impairs the rewarding effects of methamphetamine: Involvement of dopaminergic receptors in the nucleus accumbens
Asrin Sharifi, Saeideh Karimi‐Haghighi, Ronak Shabani, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 113, pp. 110458-110458
Closed Access | Times Cited: 18
Identification of the circRNA–miRNA–mRNA network for treating methamphetamine‐induced relapse and behavioral sensitization with cannabidiol
Liu Liu, Chan Wang, Haowei Wang, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 2
Hippocampal D1-like dopamine receptor as a novel target for the effect of cannabidiol on extinction and reinstatement of methamphetamine-induced CPP
Amir Mohammad Farrokhi, Fazel Moshrefi, Kiarash Eskandari, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 133, pp. 111025-111025
Closed Access | Times Cited: 2
Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets
Justin R. Yates
Substance Abuse and Rehabilitation (2024) Vol. Volume 15, pp. 125-161
Open Access | Times Cited: 2
Epigenetic Regulatory Dynamics in Models of Methamphetamine-Use Disorder
Subramaniam Jayanthi, Michael T. McCoy, Jean Lud Cadet
Genes (2021) Vol. 12, Iss. 10, pp. 1614-1614
Open Access | Times Cited: 16
Cannabidiol prevents several of the behavioral alterations related to cocaine addiction in mice
Juan Carlos Ledesma, Carmen Manzanedo, M.A. Aguilar
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 111, pp. 110390-110390
Open Access | Times Cited: 14
Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies
Dimitri Daldegan‐Bueno, Lucas Oliveira Maia, Michelle Glass, et al.
Psychopharmacology (2021) Vol. 239, Iss. 5, pp. 1211-1230
Open Access | Times Cited: 13
Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway
Baoyu Shen, Dongxian Zhang, Xiaofeng Zeng, et al.
Psychopharmacology (2022) Vol. 239, Iss. 5, pp. 1521-1537
Closed Access | Times Cited: 9
Cannabidiol enhanced the development of sensitization to the expression of methamphetamine-induced conditioned place preference in male rats
Arash Khanegheini, Masoumeh Khani, Shahram Zarrabian, et al.
Journal of Psychiatric Research (2021) Vol. 137, pp. 260-265
Closed Access | Times Cited: 12
Cannabidiol attenuates methamphetamine-induced conditioned place preference in male rats and viability in PC12 cells through the Sigma1R/AKT/GSK3β/CREB signaling pathway
Liu Liu, Juan Li, Chan Wang, et al.
The American Journal of Drug and Alcohol Abuse (2022) Vol. 48, Iss. 5, pp. 548-561
Closed Access | Times Cited: 8
Nrf2 expression, mitochondrial fission, and neuronal apoptosis in the prefrontal cortex of methamphetamine abusers and rats
Qianyun Nie, Genmeng Yang, Peng Zhang, et al.
Brain Research (2024) Vol. 1837, pp. 148973-148973
Closed Access | Times Cited: 1
Emerging medications and pharmacological treatment approaches for substance use disorders
Joel S. Raymond, Anastasios Athanasopoulos, Connie J. Badolato, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 248, pp. 173952-173952
Open Access | Times Cited: 1
Cannabidiol attenuates methamphetamine-induced cardiac inflammatory response through the PKA/CREB pathway in rats
Qianyun Nie, Wenjuan Dong, Baoyu Shen, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 18, pp. 985-985
Open Access | Times Cited: 7
Endocannabinoids and addiction memory: Relevance to methamphetamine/morphine abuse
Mirmohammadali Mirramezani Alizamini, Yonghui Li, Jianjun Zhang, et al.
The World Journal of Biological Psychiatry (2022) Vol. 23, Iss. 10, pp. 743-763
Closed Access | Times Cited: 5
Candidate Chinese Herbal Medicine Alleviates Methamphetamine Addiction via Regulating Dopaminergic and Serotonergic Pathways
Qin Ru, Qi Xiong, Xiang Tian, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 5
Cannabidiol prevents methamphetamine-induced neurotoxicity by modulating dopamine receptor D1-mediated calcium-dependent phosphorylation of methyl-CpG-binding protein 2
Baoyu Shen, Ruilin Zhang, Genmeng Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top